前列腺癌筛查的实用方法 - Suppr

Suppr

超能文献

A Pragmatic Approach to Prostate Cancer Screening.

作者信息

Tosoian Jeffrey J, Penson David F, Chinnaiyan Arul M

机构信息

Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

出版信息

JAMA. 2024 May 7;331(17):1448-1450. doi: 10.1001/jama.2024.4089.

DOI:10.1001/jama.2024.4089

PMID:38581253

Abstract

摘要

相似文献

A Pragmatic Approach to Prostate Cancer Screening.

JAMA. 2024 May 7;331(17):1448-1450. doi: 10.1001/jama.2024.4089.

Prostate Biopsy in Men with an Elevated PSA Level - Reducing Overdiagnosis.

N Engl J Med. 2024 Sep 26;391(12):1153-1154. doi: 10.1056/NEJMe2409985.

Prostate Cancer Screening and the Associated Controversy.

Surg Clin North Am. 2015 Oct;95(5):1023-39. doi: 10.1016/j.suc.2015.05.001. Epub 2015 Jun 23.

A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.

Eur J Epidemiol. 2017 Jun;32(6):521-527. doi: 10.1007/s10654-017-0292-5. Epub 2017 Jul 31.

[Current aspects of prostate cancer screening].

Semergen. 2017 Jul-Aug;43(5):387-393. doi: 10.1016/j.semerg.2016.07.002. Epub 2016 Aug 22.

Prostate-specific antigen-based prostate cancer screening: Past and future.

Int J Urol. 2015 Jun;22(6):524-32. doi: 10.1111/iju.12750. Epub 2015 Apr 6.

Active Surveillance for Low-Risk Prostate Cancer: The Uphill Battles and the Unnecessary Ones.

J Urol. 2022 Feb;207(2):265-267. doi: 10.1097/JU.0000000000002348. Epub 2021 Nov 17.

Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.

J Natl Cancer Inst. 2014 Mar;106(3):dju010. doi: 10.1093/jnci/dju010. Epub 2014 Mar 4.

Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men.

Eur Urol Oncol. 2019 May;2(3):311-319. doi: 10.1016/j.euo.2018.09.001. Epub 2018 Sep 27.

The need for active surveillance for low risk prostate cancer.

Expert Rev Anticancer Ther. 2017 Jun;17(6):487-489. doi: 10.1080/14737140.2017.1319767. Epub 2017 Apr 21.

引用本文的文献

Effect of prostate volume on the predictive value of prostate-specific antigen density for prostate cancer.

Transl Androl Urol. 2025 Jan 31;14(1):70-80. doi: 10.21037/tau-24-490. Epub 2025 Jan 22.

Lethal Prostate Cancer in Mexico: Data from the Can.Prost Mexican Registry and a Project for Early Detection.

Cancers (Basel). 2024 Oct 30;16(21):3675. doi: 10.3390/cancers16213675.

[Prostate cancer screening? Only evidence-based, risk-adjusted, and organized!].

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Sep;67(9):1047-1053. doi: 10.1007/s00103-024-03916-3. Epub 2024 Aug 5.

Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer.

Prostate Cancer Prostatic Dis. 2025 Mar;28(1):45-55. doi: 10.1038/s41391-024-00840-0. Epub 2024 Jun 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A Pragmatic Approach to Prostate Cancer Screening.

JAMA. 2024 May 7;331(17):1448-1450. doi: 10.1001/jama.2024.4089.

Prostate Biopsy in Men with an Elevated PSA Level - Reducing Overdiagnosis.

N Engl J Med. 2024 Sep 26;391(12):1153-1154. doi: 10.1056/NEJMe2409985.

Prostate Cancer Screening and the Associated Controversy.

Surg Clin North Am. 2015 Oct;95(5):1023-39. doi: 10.1016/j.suc.2015.05.001. Epub 2015 Jun 23.

A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.

Eur J Epidemiol. 2017 Jun;32(6):521-527. doi: 10.1007/s10654-017-0292-5. Epub 2017 Jul 31.

[Current aspects of prostate cancer screening].

Semergen. 2017 Jul-Aug;43(5):387-393. doi: 10.1016/j.semerg.2016.07.002. Epub 2016 Aug 22.

Prostate-specific antigen-based prostate cancer screening: Past and future.

Int J Urol. 2015 Jun;22(6):524-32. doi: 10.1111/iju.12750. Epub 2015 Apr 6.

Active Surveillance for Low-Risk Prostate Cancer: The Uphill Battles and the Unnecessary Ones.

J Urol. 2022 Feb;207(2):265-267. doi: 10.1097/JU.0000000000002348. Epub 2021 Nov 17.

Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.

J Natl Cancer Inst. 2014 Mar;106(3):dju010. doi: 10.1093/jnci/dju010. Epub 2014 Mar 4.

Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men.

Eur Urol Oncol. 2019 May;2(3):311-319. doi: 10.1016/j.euo.2018.09.001. Epub 2018 Sep 27.

The need for active surveillance for low risk prostate cancer.

Expert Rev Anticancer Ther. 2017 Jun;17(6):487-489. doi: 10.1080/14737140.2017.1319767. Epub 2017 Apr 21.

引用本文的文献

Effect of prostate volume on the predictive value of prostate-specific antigen density for prostate cancer.

Transl Androl Urol. 2025 Jan 31;14(1):70-80. doi: 10.21037/tau-24-490. Epub 2025 Jan 22.

Lethal Prostate Cancer in Mexico: Data from the Can.Prost Mexican Registry and a Project for Early Detection.

Cancers (Basel). 2024 Oct 30;16(21):3675. doi: 10.3390/cancers16213675.

[Prostate cancer screening? Only evidence-based, risk-adjusted, and organized!].

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Sep;67(9):1047-1053. doi: 10.1007/s00103-024-03916-3. Epub 2024 Aug 5.

Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer.

Prostate Cancer Prostatic Dis. 2025 Mar;28(1):45-55. doi: 10.1038/s41391-024-00840-0. Epub 2024 Jun 10.